Werewolf Therapeutics (HOWL) EPS (Basic) (2020 - 2026)
Werewolf Therapeutics' (HOWL) quarterly EPS (Basic) came in at $0.14 in Q2 2026, up 135.8% year-over-year from $0.06 in Q2 2025, and up 148.99% quarter-over-quarter from -$0.29 in Q1 2026.
Powered by 
Analysis
Werewolf Therapeutics (HOWL) EPS (Basic) (2020 - 2026) Analysis & Trends
Werewolf Therapeutics (HOWL) has reported EPS (Basic) for 7 consecutive years, with $0.14 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EPS (Basic) rose 135.8% year-over-year to $0.14 in Q2 2026; TTM through Jun 2026 was -$0.7, a 57.28% increase from a year earlier, with the FY2025 full-year figure at -$1.37, up 17.33% from the prior year.
- EPS (Basic) was $0.14 for Q2 2026 at Werewolf Therapeutics, up from -$0.29 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.14 in Q2 2026 and troughed at -$0.56 in Q1 2022.
- A 5-year average of -$0.34 and a median of -$0.39 in 2024 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) plunged 194.87% in 2024 and jumped 135.8% in 2026, its largest moves.
- Over 5 years, EPS (Basic) stood at -$0.41 in 2022, then rose by 18.57% to -$0.34 in 2023, then tumbled by 39.24% to -$0.47 in 2024, then soared by 52.59% to -$0.22 in 2025, then soared by 164.47% to $0.14 in 2026.
- The last three EPS (Basic) figures came in at $0.14 (Q2 2026), -$0.29 (Q1 2026), and -$0.22 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.01 Bn | 193.02 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.98 Bn | 176.80 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 82.02 Bn | 74.03 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.35 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 53.69 Bn | 48.55 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.11 Bn | 29.80 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.21 Bn | 29.21 Bn | 1.16 Mn | -0.40 |
| 10 | Werewolf Therapeutics | 47.70 Mn | 47.70 Mn | - | 0.14 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.14 |
| Mar 31, 2026 | -0.29 |
| Dec 31, 2025 | -0.22 |
| Sep 30, 2025 | -0.36 |
| Jun 30, 2025 | -0.40 |
| Mar 31, 2025 | -0.41 |
| Dec 31, 2024 | -0.47 |
| Sep 30, 2024 | -0.38 |
| Jun 30, 2024 | -0.42 |
| Mar 31, 2024 | -0.39 |
| Dec 31, 2023 | -0.34 |
| Sep 30, 2023 | -0.23 |
| Jun 30, 2023 | -0.14 |
| Mar 31, 2023 | -0.31 |
| Dec 31, 2022 | -0.41 |
| Sep 30, 2022 | -0.40 |
| Jun 30, 2022 | -0.53 |
| Mar 31, 2022 | -0.56 |
| Dec 31, 2021 | -0.97 |
| Sep 30, 2021 | -0.51 |